NEW YORK (GenomeWeb) – Affymetrix today announced a global partnership with Athletigen Technologies to use the Axiom genotyping platform in its sports-related direct-to-consumer genetic analysis service.

The Athletigen microarray analyzes 850,000 genetic variants that it claims can influence human athletic performance.

Financial and other terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.